Center for Scientific Review; Notice of Closed Meetings
Published Date: 11/25/2025
Notice
Summary
The Center for Scientific Review is holding a closed virtual meeting on December 17, 2025, to review grant applications for clinical neuroscience career awards. These meetings are private to protect sensitive information and personal privacy. Researchers applying for funding and the NIH are affected, with timely reviews helping speed up important health research funding decisions.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Closed Grant Review Protects Privacy
On December 17, 2025, the NIH Center for Scientific Review will hold a closed virtual meeting to evaluate Career Development Awards for Clinical Neuroscience Professionals. The meeting is closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property (like patentable material), and personal information of applicants.
Timely Reviews Speed Funding Decisions
The closed meeting on December 17, 2025, will review and evaluate grant applications so evaluations can be submitted to national advisory councils for timely funding recommendations. Researchers applying for these clinical neuroscience career awards and the NIH are affected because timely reviews help move funding decisions forward.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice
The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13204 — Proposed Collection; 30-Day Comment Request; NIH Information Collection Forms to Support the Genetic Testing Registry (OD)
The NIH wants your thoughts on updating forms that help track genetic tests in their registry. If you’re involved in genetic testing or research, these changes could affect how you share info. You’ve got until July 30, 2026, to send in your comments—no cost, just your voice to help make things smoother and smarter!
2026-12844 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings on July 17, 2026, to review important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants in brain injury, neurobehavior, nanotech, and heart/lung studies should note these review dates and prepare accordingly.
2026-12843 — Government Owned Inventions Available for License: C8166-45 Cell Line
The National Cancer Institute is offering a special human T-cell line called C8166-45 for licensing. This cell line helps scientists study viruses like HTLV-1 and HIV, which can cause serious diseases. Researchers and companies can now use this tool to develop better treatments, with licensing info available starting June 2026—no patents, just pure science power ready to roll!
Previous / Next Documents
Previous: 2025-20839 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding a closed virtual meeting on January 6, 2026, to review grant applications about eye disease. These meetings are private to protect secret research info and personal details. Scientists applying for grants and NIH staff are involved, with no new costs or timing changes announced.
Next: 2025-20841 — Palisades Energy, LLC; Palisades Nuclear Plant; Exemption
Palisades Energy, LLC got a special okay from the Nuclear Regulatory Commission to relax work hour rules at the Palisades Nuclear Plant for 60 days starting November 3, 2025. This one-time break helps the plant manage its staff better without extra costs or delays. Workers and the plant’s operations will feel the change during this short, focused period.